Agenus to Host March 2026 Stakeholder Webcast Harnessing the Immune System to Advance BOT + BAL Across Tumor Types and Expand Patient Access

Agenus to Host March 2026 Stakeholder Webcast Harnessing the Immune System to Advance BOT + BAL Across Tumor Types and Expand Patient Access Mar 26, 2026 4:52 PM Eastern Daylight Time Agenus to Host March 2026 Stakeholder Webcast Harnessing the Immune System to Advance BOT + BAL Across Tumor Types and Expand Patient Access Share Webcast on Tuesday, March 31, 2026, at 4:30 p.m. ET LEXINGTON, Mass.--(BUSINESS WIRE)-- Agenus Inc.("Agenus†) (Nasdaq: AGEN), a leader in immuno-oncology, today announced it will ...